The rising need for protein-based treatments (biologics), the high frequency of lifestyle diseases, infectious diseases, and genetic disorders, and increased financing for protein research are all contributing to the market’s rise. High market consolidation, which raises entry barriers, and the high cost of protein treatment, on the other hand, are the key issues limiting the […]